FI109996B - Menetelmä terapeuttisesti käyttökelpoisen D-vitamiinisarjan 25-karboksyylihappojohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisen D-vitamiinisarjan 25-karboksyylihappojohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI109996B
FI109996B FI951614A FI951614A FI109996B FI 109996 B FI109996 B FI 109996B FI 951614 A FI951614 A FI 951614A FI 951614 A FI951614 A FI 951614A FI 109996 B FI109996 B FI 109996B
Authority
FI
Finland
Prior art keywords
carboxylic acid
ester
trihydroxy
tetraene
methyl
Prior art date
Application number
FI951614A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI951614A (fi
FI951614A0 (fi
Inventor
Martin Haberey
Guenter Neef
Gerald Kirsch
Andreas Steinmeyer
Katica Schwarz
Herbert Wiesinger
Ruth Thieroffekerdt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4234382A external-priority patent/DE4234382A1/de
Priority claimed from DE19934317415 external-priority patent/DE4317415A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI951614A publication Critical patent/FI951614A/fi
Publication of FI951614A0 publication Critical patent/FI951614A0/fi
Application granted granted Critical
Publication of FI109996B publication Critical patent/FI109996B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
FI951614A 1992-10-06 1995-04-05 Menetelmä terapeuttisesti käyttökelpoisen D-vitamiinisarjan 25-karboksyylihappojohdannaisten valmistamiseksi FI109996B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4234382 1992-10-06
DE4234382A DE4234382A1 (de) 1992-10-06 1992-10-06 25-Carbonsäure-Derivate in der Vitamin D-Reihe, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
DE19934317415 DE4317415A1 (de) 1993-05-18 1993-05-18 25-Carbonsäure-Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für diese Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
DE4317415 1993-05-18
EP9302814 1993-10-06
PCT/EP1993/002814 WO1994007853A1 (de) 1992-10-06 1993-10-06 25-carbonsäure-derivate in der vitamin d-reihe, verfahren zu ihrer herstellung, zwischenprodukte für diese verfahren, diese derivate enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln

Publications (3)

Publication Number Publication Date
FI951614A FI951614A (fi) 1995-04-05
FI951614A0 FI951614A0 (fi) 1995-04-05
FI109996B true FI109996B (fi) 2002-11-15

Family

ID=25919406

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951614A FI109996B (fi) 1992-10-06 1995-04-05 Menetelmä terapeuttisesti käyttökelpoisen D-vitamiinisarjan 25-karboksyylihappojohdannaisten valmistamiseksi

Country Status (21)

Country Link
US (1) US5583125A (ko)
EP (1) EP0663902B1 (ko)
JP (1) JP3565847B2 (ko)
KR (1) KR100294600B1 (ko)
CN (1) CN1042026C (ko)
AT (1) ATE163923T1 (ko)
AU (1) AU671313B2 (ko)
CA (1) CA2146429C (ko)
CZ (1) CZ284926B6 (ko)
DE (1) DE59308257D1 (ko)
DK (1) DK0663902T3 (ko)
ES (1) ES2117150T3 (ko)
FI (1) FI109996B (ko)
HU (1) HU221588B (ko)
IL (1) IL107185A (ko)
MX (1) MX9306204A (ko)
NO (1) NO309599B1 (ko)
NZ (1) NZ256862A (ko)
PL (1) PL175636B1 (ko)
SK (1) SK280651B6 (ko)
WO (1) WO1994007853A1 (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4220757A1 (de) * 1992-06-24 1994-01-05 Schering Ag Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
AU666563B2 (en) * 1992-08-07 1996-02-15 Wisconsin Alumni Research Foundation Preparation of 19-nor-vitamin D compounds
CA2166898C (en) * 1993-07-09 2004-09-07 Roger Bouillon Novel structural analogues of vitamin d
GB9315253D0 (en) * 1993-07-23 1993-09-08 Res Inst Medicine Chem Chemical compounds
WO1997000242A1 (de) * 1995-06-14 1997-01-03 Schering Aktiengesellschaft Neue vitamin d-derivate mit substituenten an c-25, verfahren zu ihrer herstellung, zwischenprodukte und die verwendung zur herstellung von arzneimitteln
DE19549243A1 (de) * 1995-12-21 1997-06-26 Schering Ag Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga
WO1997032998A2 (en) * 1996-03-08 1997-09-12 Isis Innovation Limited Materials and methods relating to the identification of a polymorphism associated with disease susceptibility
WO1999012894A1 (en) * 1997-09-08 1999-03-18 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
DE19744127B4 (de) * 1997-10-01 2006-10-05 Schering Ag Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln
EP1042335A1 (de) * 1997-12-17 2000-10-11 Schering Aktiengesellschaft Vitamin d-derivate mit phosphoratomen in den seitenketten
EP0927721A1 (de) * 1997-12-17 1999-07-07 Schering Aktiengesellschaft Neue Vitamin D-Derivate mit Phosphoratomen in den Seitenketten, Zwischenprodukte bei ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
WO2000024712A1 (fr) 1998-10-23 2000-05-04 Teijin Limited Derives de vitamine d3 et medicaments contre des maladies respiratoires inflammatoires les contenant
US20030188756A1 (en) * 2002-08-19 2003-10-09 Cantorna Margherita T Treatment of inflammatory bowel disease with vitamin d compounds
EP1233942A2 (en) * 1999-12-02 2002-08-28 The Penn State Research Foundation Treatment of inflammatory bowel disease with vitamin d compounds
US6989377B2 (en) * 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) * 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
DE10156596A1 (de) * 2001-11-13 2003-05-28 Schering Ag Vitamin D-Derivate mit Acyloxygruppen in der Seitenkette, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
EP1342796A3 (en) * 2002-02-22 2004-01-02 Teijin Limited Compound for the treatment of paget's disease of bone
WO2004046097A1 (en) * 2002-11-18 2004-06-03 Teva Pharmaceutical Industries Ltd. A crystallization method for purification of calcipotriene
US7704980B2 (en) * 2003-10-08 2010-04-27 Wisconsin Alumni Research Foundation Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
US7888339B2 (en) 2008-07-10 2011-02-15 Wisconsin Alumni Research Foundation 2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
JPWO2010053165A1 (ja) 2008-11-04 2012-04-05 帝人ファーマ株式会社 ビタミンｄ３ラクタム誘導体
SG173119A1 (en) 2009-01-27 2011-08-29 Berg Biosystems Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
EP3603646B1 (en) 2009-08-14 2024-04-03 BPGbio, Inc. Vitamin d3 and analogs thereof for treating alopecia
CN112156097A (zh) 2013-05-29 2021-01-01 博格有限责任公司 使用维生素d预防或减轻化疗诱发的脱发
US10314395B2 (en) 2017-02-21 2019-06-11 James E. McGhee, III Pallet spacer system and method of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022891A (en) * 1974-06-18 1977-05-10 Teijin Limited Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them
DE3666587D1 (en) * 1985-08-02 1989-11-30 Leo Pharm Prod Ltd Novel vitamin d analogues
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
DE3933034A1 (de) * 1989-10-02 1991-04-11 Schering Ag 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung
HU221008B1 (hu) * 1991-11-07 2002-07-29 Research Institute For Medicine And Chemistry D-vitamin-származékok és azokat tartalmazó gyógyászati készítmények
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate

Also Published As

Publication number Publication date
IL107185A0 (en) 1994-01-25
US5583125A (en) 1996-12-10
NO951318L (no) 1995-06-02
CN1042026C (zh) 1999-02-10
AU671313B2 (en) 1996-08-22
SK280651B6 (sk) 2000-05-16
CA2146429C (en) 2006-12-05
WO1994007853A1 (de) 1994-04-14
CZ87395A3 (en) 1995-10-18
NZ256862A (en) 1996-03-26
HU221588B (hu) 2002-11-28
MX9306204A (es) 1994-05-31
PL308260A1 (en) 1995-07-24
JPH08501784A (ja) 1996-02-27
DE59308257D1 (de) 1998-04-16
SK45895A3 (en) 1995-08-09
EP0663902B1 (de) 1998-03-11
NO309599B1 (no) 2001-02-26
NO951318D0 (no) 1995-04-05
HUT70562A (en) 1995-10-30
ATE163923T1 (de) 1998-03-15
CZ284926B6 (cs) 1999-04-14
AU5177193A (en) 1994-04-26
CN1094034A (zh) 1994-10-26
HU9501002D0 (en) 1995-06-28
DK0663902T3 (da) 1998-12-21
KR950703526A (ko) 1995-09-20
EP0663902A1 (de) 1995-07-26
IL107185A (en) 1998-02-22
KR100294600B1 (ko) 2001-09-17
PL175636B1 (pl) 1999-01-29
CA2146429A1 (en) 1994-04-14
JP3565847B2 (ja) 2004-09-15
FI951614A (fi) 1995-04-05
FI951614A0 (fi) 1995-04-05
ES2117150T3 (es) 1998-08-01

Similar Documents

Publication Publication Date Title
FI109996B (fi) Menetelmä terapeuttisesti käyttökelpoisen D-vitamiinisarjan 25-karboksyylihappojohdannaisten valmistamiseksi
AU707942B2 (en) New vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents
JP3207423B2 (ja) ビタミンｄ系列の２３−オキサ誘導体、その製造法、該誘導体を含有する製薬学的調剤ならびに医薬品としての該誘導体の使用
FR2634200A1 (fr) Nouveaux composes derives de la vitamine d, leur procede de preparation et compositions pharmaceutiques contenant ces composes
EP0742203B1 (en) Vitamin D compounds and method of preparing these compounds
HUT68263A (en) 20-methyl-substituted vitamin d derivatives, process for their production, pharmaceutical compositions and intermediates
NZ253026A (en) 20-alkynyl-9,10-seco-pregna-5(z),7(e),10(19),17(20)(e)-tetraene (vitamin d) derivatives and pharmaceutical compositions
US5532228A (en) Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
HUT70563A (en) Process for producing vitamin d derivatives modified at the 20 position, pharmaceutical compositions containing the same and intermediates
KR100399661B1 (ko) 비타민d및아마이드유도체
JP3589664B2 (ja) ビタミンｄ系列の２２−エン−２５−オキサ−誘導体，該化合物の製造法，該誘導体を含有する薬学的調剤ならびに薬剤としての該調剤の使用
US6310226B1 (en) Vitamin D analogues
US20040229851A1 (en) 2-Propylidene-19-nor-vitamin D compounds
US6441207B1 (en) Method for making hydroxy-25-ene-vitamin D compounds
JP3589413B2 (ja) ２２−メチルビタミンｄ誘導体
JP3633639B2 (ja) ビタミンｄ化合物およびそれらの製造方法